Izurieta HS, Wu X, Forshee R, Lu Y, et al. Recombinant Zoster Vaccine (Shingrix) real-world effectiveness in the first two years post-licensure. Clin Infect Dis 2021 Feb 13. pii: 6134290. doi: 10.1093.
PMID: 33580242